FABRIS, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 20.124
EU - Europa 2.681
AS - Asia 2.265
AF - Africa 20
SA - Sud America 17
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.118
Nazione #
US - Stati Uniti d'America 20.112
CN - Cina 962
SG - Singapore 870
IT - Italia 718
FI - Finlandia 482
DE - Germania 305
SE - Svezia 297
VN - Vietnam 255
FR - Francia 254
UA - Ucraina 214
GB - Regno Unito 142
RU - Federazione Russa 126
HK - Hong Kong 85
NL - Olanda 51
IN - India 49
IE - Irlanda 34
JP - Giappone 14
ES - Italia 13
AT - Austria 9
CA - Canada 9
MA - Marocco 9
CH - Svizzera 8
IR - Iran 8
BR - Brasile 7
TR - Turchia 7
CM - Camerun 6
AR - Argentina 5
AU - Australia 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
BG - Bulgaria 3
EU - Europa 3
IL - Israele 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
CO - Colombia 2
EC - Ecuador 2
GR - Grecia 2
HR - Croazia 2
KR - Corea 2
MX - Messico 2
RO - Romania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
KE - Kenya 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SM - San Marino 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 25.118
Città #
Fairfield 3.477
Woodbridge 2.216
Houston 1.716
Ashburn 1.334
Ann Arbor 1.308
Seattle 1.288
Wilmington 1.233
Chandler 1.221
Cambridge 1.197
Jacksonville 1.031
Singapore 629
Princeton 522
Boardman 429
San Diego 350
Santa Clara 322
Dong Ket 255
Medford 222
Roxbury 220
Helsinki 193
Nanjing 192
Beijing 190
Padova 163
Des Moines 107
Hong Kong 82
Hebei 65
Nanchang 65
Guangzhou 63
Norwalk 54
Shenyang 53
New York 49
Jiaxing 48
Milan 42
London 41
Jinan 35
Rome 34
Dublin 33
Changsha 31
Redwood City 31
Tianjin 27
Kilburn 19
Ogden 15
Borås 12
Catania 12
Florence 10
Indiana 10
Kharkiv 10
Nuremberg 10
Turin 10
Dearborn 9
Hefei 9
Bologna 8
Lanzhou 8
Palermo 8
Paris 8
Kunming 7
Orange 7
Rockville 7
Tappahannock 7
Detroit 6
Douala 6
Hangzhou 6
Legnaro 6
Naples 6
Ningbo 6
Osaka 6
San Francisco 6
Vienna 6
Zhengzhou 6
Castiglione 5
Haikou 5
Pollena Trocchia 5
Rabat 5
Washington 5
Yellow Springs 5
Acton 4
Costa Mesa 4
Dresden 4
Dronten 4
Falls Church 4
Frankfurt am Main 4
Genoa 4
Guardiagrele 4
Hounslow 4
Los Angeles 4
Messina 4
Monselice 4
Montesilvano Marina 4
Monza 4
Mykolayiv 4
Nutley 4
Perugia 4
Selargius 4
Selvazzano Dentro 4
Shanghai 4
Verona 4
Vicenza 4
Zurich 4
Ailoche 3
Amsterdam 3
Ardabil 3
Totale 20.945
Nome #
Mappatura Genetica dell' Ipercolesterolemia Familiare: dati preliminari dell'esperienza padovana 269
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 198
Low vitamin K1 intake in haemodialysis patients 196
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 178
Vitamin K plasma levels determination in human health 174
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 173
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 168
Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia. 164
Weight loss reduces anti-ADAMTS13 autoantibodies and improves inflammatory and coagulative parameters in obese patients 157
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. 153
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod 145
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 145
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 141
Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement. 137
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 135
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients 134
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 131
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 129
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 128
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 128
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 127
Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia 127
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia 126
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 122
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 121
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. 120
Presence of anti-ADAMTS13 antibodies in obesity. 120
Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multi-center Italian study 120
Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. 119
Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis 117
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 117
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 116
Selection of both normal and bleeding patients is indicated before desmopressin administration 116
Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. 114
Sindromi mieloproliferative croniche: La trombocitemia essenziale 114
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. 114
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 113
A tentative classification of factor XIII deficiency in two groups. 113
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 113
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011 113
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis 112
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations. 111
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. 111
Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies. 110
Multiple, relapsing thrombosis in a young man with primary thrombocytosis 110
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. 110
Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission 110
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients. 110
Heparin induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies 109
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the Jak2 (V617F) mutation 109
A 29-year-old woman with persistent thrombocytopenia 109
Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia. 108
The significance of plasma and /or platelet activated products after apheresis procedures 108
Splenomegaly as the first manifestation of thyroid cancer metastases 107
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation 107
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 106
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 106
Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura. 105
A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding. 103
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 103
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 103
The significance of thrombocytosis in old age 102
Normal and low molecular weight heparins: interaction with human platelets 102
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients 102
JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia. 101
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 100
Spectrum of the Mutations in Bernard-Soulier Syndrome 100
Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. 99
Clinical and laboratory factors that affect the post-transfusion platelet increment 99
Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. 99
New heterozygous variant in GP1BB gene is responsible for an inherited form of macrothrombocytopenia 99
Additional evidence against the presence of inhibitors in vit. K deficiency and in coumarin-treated patients. 98
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 98
Familial thrombocythemia and/or thrombocytosis: apparently a rare disorder 97
Labeling of platelet surface glycoproteins with biotin derivatives 97
Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study 97
A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome 97
HOW MANY CHILDREN WITH THROMBOCYTOSIS OF UNDEFINED ORIGIN HAVE A MYELOPROLIFERATIVE NEOPLASM? 96
Heavy chain myosin 9-related disease (MYH9 -RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 96
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 96
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura 96
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. 95
A 40-years-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis 95
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A. 95
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation: Implications for Risk and Therapy. 95
Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines 95
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 95
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 95
Genetic Diagnosis of Familial Hypercholesterolaemia: preliminary data from the University of Padua outpatient lipid clinic. 94
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 94
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 94
Histology of the spleen in Immune Thrombocytopenia: clinical-pathological characterization and prognostic implications 94
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 93
Clinical significance of beta-thromboglobulin in patients with high platelet count 93
Effect of busulfan on JAK2V617F allele burden. 93
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 93
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 93
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature 92
Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). 92
Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies. 92
Totale 11.565
Categoria #
all - tutte 92.262
article - articoli 90.324
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.829 0 0 0 0 0 0 0 544 984 582 433 286
2020/20214.208 299 336 299 251 139 208 67 449 505 549 421 685
2021/20224.315 104 478 389 504 205 266 159 478 249 84 398 1.001
2022/20232.676 683 189 88 275 398 308 17 215 315 33 124 31
2023/20241.210 64 152 118 115 81 99 63 50 43 22 191 212
2024/20252.482 29 469 347 239 901 147 265 85 0 0 0 0
Totale 25.379